Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 November 2014 11:55
Experts have found that eribulin can extend the lives of women with aggressive forms of breast cancer by several months
Giving breast cancer patients a drug made from sea sponges can extend their lives by several months, according to a new study.
Researchers at the University of Leeds carried out two large-scale trials with more than 1,800 participants who had been diagnosed with metastatic breast cancer.
They found that the drug eribulin extended the women's survival by an average of more than two months.
Women who had advanced triple negative breast cancer - an aggressive form of the disease for which there are few treatment options - benefited the most from the drug, with their lifespans increasing by almost five months.
Those with HER2 negative breast cancer lived more than two months longer when given eribulin, it was found.
Martin Ledwick, head information nurse at Cancer Research UK, described the results as "encouraging" for those women whose cancers no longer respond to conventional treatments.
He said that eribulin is not a cure but an additional option to extend patients' lives - which could be "priceless" for the women and their families. It may give them the option to spend valuable time with their family and friends, or to embark on a holiday with the security provided by specialist travel insurance for cancer patients.
The drug was originally derived from Halichondria okadai, a sea sponge, although it is now produced in laboratories.
Chris Twelves, professor of clinical cancer pharmacology and oncology at the University of Leeds, said the findings show that eribulin can lead to a "substantial improvement" in women's survival rates.
He pointed out that, while the drug was previously only available for women who had undergone several rounds of chemotherapy, the EU has now also approved it for those who have not received as much treatment.
The findings of the study were presented at the National Cancer Research Institute's cancer conference in Liverpool.
19 July 2018
The flu vaccination does not appear to have been effective in protecting against so-called Aussie flu, figures show.
[more...]
18 July 2018
Bowel cancer screening tests could also provide an insight into whether patients are at risk of other illnesses, a new study has revealed.
17 July 2018
France is still celebrating today after its national football team brought home football's biggest prize after a thrilling final in Moscow.
14 July 2018
Too many passengers heading abroad this summer will be travelling without adequate protection for when an airline goes bust, a new study has shown.
13 July 2018
The mother of Bradley Lowery has welcomed the news that a drug used to help treat her son will soon be made available for other patients on the NHS.
12 July 2018
British GPs have prevented thousands of strokes after learning how to better identify and treat a common heart condition, research has shown.
11 July 2018
London City Airport is considering lodging an application to increase flight and passenger numbers, its boss has revealed.
10 July 2018
Captain Harry Kane is leading England's unexpected bid for glory, and is hoping to inspire the next generation of footballers by going all the way in Russia.
07 July 2018
Experts have warned that a lack of rigorous testing of skin cancer detection apps is putting the public at risk.
06 July 2018
Easyjet has added to worries that travellers are set for a summer of chaos, revealing that nearly 1,300 flights were cancelled last month.
05 July 2018
Soaring temperatures across the UK have led to a surge of asthma sufferers calling a dedicated asthma helpline, a charity has revealed.
04 July 2018
Strikes across Europe led Ryanair to cancel over 1,000 flights in June, the budget airline has revealed.